,940
CASH FLOWS FROM INVESTING ACTIVITIES:
Other receivables - related party -- 2,570,100
Purchase plant and equipment (9,679) (154,262)
Proceeds from equipment disposal 5,125,750 35,266
Additions to construction in progress (4,810,511) (7,725,153)
Acquisition of land use right (480,356) (324,031)
Purchase of software program -- (5,426)
Advances on plant and equipment
purchase -- (9,876,385)
Loan repayment from related party -- 678,200
Proceed from land use right disposal -- 30,826
Net cash used in investing
activities (174,796) (14,770,865)
CASH FLOWS FROM FINANCING ACTIVITIES:
Decrease in restricted cash (2,201,573) 3,407,360
Borrowings on notes payable - banks 16,607,430 5,425,600
Payments on notes payable - banks (14,410,680) (10,579,920)
Borrowings on short term loans 13,722,365 12,750,160
Payments on short term loans (13,766,300) (11,380,196)
Borrowings on employee loans 392,147 1,412,554
Payments on employee loans (938,635) (459,082)
Borrowings on employee loan - officer -- 45,187
Other receivables - shareholder (10,252) 1,273,495
Borrowings on third party loan 113,650 2,898,529
Payments on third party loan (563,715) (2,826,195)
Payment on other payable - equipment
purchase (1,033,127) (614,633)
Cash pro
'/>"/>SOURCE Shengtai Pharmaceutical, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 Related medicine news :1.
Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call2.
Shengtai Pharmaceutical Hosts Key Customers at Its Headquarters for Facility Tour and Technology Exchange Conference3.
Shengtai Pharmaceutical, Inc. Comments On Its Operations4.
Shengtai Pharmaceutical Schedules 2009 Second Quarter Financial Results and Conference Call5.
Shengtai Pharmaceutical, Inc. Comments on Chinas Recently Approved Health Care Reform Plan6.
Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference7.
Shengtai Pharmaceutical Expands International Sales Program8.
Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 20089.
Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 200810.
Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 200811.
Shengtai Pharmaceutical, Inc. to Present at Roth Conference